Nuveen Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$10.7M Sell
358,952
-5,601
-2% -$167K ﹤0.01% 1564
2024
Q3
$5.7M Sell
364,553
-79,146
-18% -$1.24M ﹤0.01% 1922
2024
Q2
$7.6M Buy
443,699
+154,590
+53% +$2.65M ﹤0.01% 1739
2024
Q1
$4.52M Sell
289,109
-23,570
-8% -$368K ﹤0.01% 2041
2023
Q4
$4.67M Sell
312,679
-15,981
-5% -$239K ﹤0.01% 2022
2023
Q3
$5.31M Buy
328,660
+31,894
+11% +$515K ﹤0.01% 1834
2023
Q2
$12.3M Sell
296,766
-4,616
-2% -$192K ﹤0.01% 1373
2023
Q1
$18.1M Sell
301,382
-375
-0.1% -$22.6K 0.01% 1109
2022
Q4
$22.1M Sell
301,757
-62,259
-17% -$4.57M 0.01% 970
2022
Q3
$27.7M Buy
364,016
+10,224
+3% +$777K 0.01% 817
2022
Q2
$24.6M Sell
353,792
-6,633
-2% -$461K 0.01% 905
2022
Q1
$28.3M Sell
360,425
-296
-0.1% -$23.2K 0.01% 964
2021
Q4
$27.1M Sell
360,721
-39,907
-10% -$3M 0.01% 1046
2021
Q3
$46.5M Sell
400,628
-90,203
-18% -$10.5M 0.01% 722
2021
Q2
$109M Buy
490,831
+20,043
+4% +$4.45M 0.03% 447
2021
Q1
$62.2M Sell
470,788
-17,269
-4% -$2.28M 0.02% 626
2020
Q4
$84.5M Buy
488,057
+133,149
+38% +$23M 0.03% 482
2020
Q3
$39.5M Buy
354,908
+108,073
+44% +$12M 0.02% 673
2020
Q2
$14.6M Sell
246,835
-318,704
-56% -$18.9M 0.01% 1237
2020
Q1
$38.1M Buy
565,539
+87,328
+18% +$5.88M 0.02% 588
2019
Q4
$40.3M Sell
478,211
-6,785
-1% -$572K 0.02% 783
2019
Q3
$36.3M Sell
484,996
-23,176
-5% -$1.73M 0.01% 822
2019
Q2
$30.9M Buy
508,172
+483,912
+1,995% +$29.4M 0.01% 922
2019
Q1
$1.17M Sell
24,260
-217,468
-90% -$10.5M 0.01% 716
2018
Q4
$8.09M Sell
241,728
-173,182
-42% -$5.8M 0.05% 423
2018
Q3
$21.7M Sell
414,910
-21,775
-5% -$1.14M 0.12% 281
2018
Q2
$13.7M Buy
436,685
+138,257
+46% +$4.33M 0.09% 333
2018
Q1
$6.51M Buy
+298,428
New +$6.51M 0.04% 446